Primary Hypogonadism Due To Orchitis — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for primary hypogonadism due to orchitis. 36 active patents protecting 1 drugs from 1+ originators. First major cliff: 2026. Daily refresh.

1
Approved drugs
36
Active US patents
72/100
Avg vulnerability
—
Annual revenue covered

Originators in Primary Hypogonadism Due To Orchitis

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Besins Hlthcare 36 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating primary hypogonadism due to orchitis. Each bar = one year. Y-axis scaled to peak year (24 patents).

24
26
4
27
8
34

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Androgel
TESTOSTERONE
 Besins Hlthcare 36 72 — 2026-10-12

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8466137 Androgel method of use 85 2026-10-12
8741881 Androgel method of use 85 2026-10-12
8741881 Androgel method of use 85 2026-10-12
8466138 Androgel method of use 85 2026-10-12
8466138 Androgel method of use 85 2026-10-12
8466137 Androgel method of use 85 2026-10-12
8466137 Androgel method of use 85 2026-10-12
8466138 Androgel method of use 85 2026-10-12
8741881 Androgel method of use 85 2026-10-12
8419307 Androgel method of use 85 2027-02-26

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
11090312 Androgel method of use 62 2034-03-17
9295675 Androgel method of use 62 2034-02-11
9662340 Androgel method of use 62 2034-02-11
9295675 Androgel method of use 62 2034-02-11
9662340 Androgel method of use 62 2034-02-11
8754070 Androgel formulation 65 2026-10-12
8754070 Androgel formulation 65 2026-10-12
8759329 Androgel formulation 65 2026-10-12
8759329 Androgel formulation 65 2026-10-12
8486925 Androgel formulation 65 2026-10-12

Related